Patents-Review.com
🔗 Permalink
Assignee profile:

AVIDITY BIOSCIENCES, INC.

City:

La Jolla, California

Country:

United States

Published Applications:

25

Last publication date:

2022-06-21

Patent Grants:

25

Last grant date:

2022-06-21

Top Inventors for applications by AVIDITY BIOSCIENCES, INC.

These are the the leading inventors for applications assigned to AVIDITY BIOSCIENCES, INC.:

Recent patent applications by AVIDITY BIOSCIENCES, INC.

AVIDITY BIOSCIENCES, INC. based in La Jolla, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2022-06-21 ✅ Patent 11,364,302 granted on 2022-06-21
US17364754
Human necessities

Nucleic acid-polypeptide compositions and uses thereof

 #2 | 2022-05-05 ✅ Patent 11,576,980 granted on 2023-02-14
US20220133900A1
Human necessities

Compositions and methods of treating muscle atrophy and myotonic dystrophy

 #3 | 2022-03-10 ✅ Patent 11,400,163 granted on 2022-08-02
US20220072145A1
Human necessities

Nucleic acid-polypeptide compositions and methods of inducing exon skipping

 #4 | 2022-03-03 ✅ Patent 11,497,814 granted on 2022-11-15
US20220062434A1
Human necessities

Compositions and methods of treating muscle atrophy and myotonic dystrophy

 #5 | 2022-02-10 ✅ Patent 11,712,478 granted on 2023-08-01
US20220040323A1
Human necessities

Compositions and methods of treating muscle atrophy and myotonic dystrophy

 #6 | 2022-01-13 ✅ Patent 11,554,176 granted on 2023-01-17
US20220008550A1
Human necessities

Compositions and methods of treating muscle atrophy and myotonic dystrophy

 #7 | 2021-12-02 ✅ Patent 11,525,137 granted on 2022-12-13
US20210369762A1
Human necessities

Compositions and methods of treating Facioscapulohumeral muscular dystrophy

 #8 | 2021-09-30 ✅ Patent 11,446,387 granted on 2022-09-20
US20210299266A1
Human necessities

Compositions and methods of treating muscle dystrophy

 #9 | 2021-08-26 ✅ Patent 11,834,510 granted on 2023-12-05
US20210261679A1
Chemistry; metallurgy

Anti-transferrin receptor antibodies and uses thereof

 #10 | 2021-06-24 ✅ Patent 11,246,941 granted on 2022-02-15
US20210187116A1
Human necessities

Compositions and methods of treating muscle atrophy and myotonic dystrophy

 #11 | 2021-05-06 ✅ Patent 11,028,179 granted on 2021-06-08
US20210130486A1
Chemistry; metallurgy

Anti-transferrin receptor antibodies and uses thereof

 #12 | 2020-12-31 ✅ Patent 11,253,607 granted on 2022-02-22
US20200405877A1
Human necessities

Compositions and methods of treating muscle atrophy and myotonic dystrophy

 #13 | 2020-12-10 ✅ Patent 11,578,090 granted on 2023-02-14
US20200385414A1
Chemistry; metallurgy

Nucleic acid-polypeptide compositions and uses thereof

 #14 | 2020-10-15 ✅ Patent 10,913,800 granted on 2021-02-09
US20200325237A1
Chemistry; metallurgy

Anti-transferrin receptor antibodies and uses thereof

 #15 | 2019-10-03 ✅ Patent 10,881,743 granted on 2021-01-05
US20190298847A1
Human necessities

Compositions and methods of treating muscle atrophy and myotonic dystrophy

 #16 | 2019-06-27 ✅ Patent 11,110,180 granted on 2021-09-07
US20190192681A1
Human necessities

Nucleic acid-polypeptide compositions and uses thereof

 #17 | 2019-02-28 ✅ Patent 10,787,519 granted on 2020-09-29
US20190062437A1
Chemistry; metallurgy

Nucleic acid-polypeptide compositions and uses thereof

 #18 | 2019-02-28 ✅ Patent 10,800,848 granted on 2020-10-13
US20190062436A1
Chemistry; metallurgy

Nucleic acid-polypeptide compositions and uses thereof

 #19 | 2019-01-03 ✅ Patent 10,487,149 granted on 2019-11-26
US20190000987A1
Human necessities

Nucleic acid-polypeptide compositions and uses thereof

 #20 | 2019-01-03 ✅ Patent 11,179,472 granted on 2021-11-23
US20190000986A1
Human necessities

Nucleic acid-polypeptide compositions and methods of inducing exon skipping

 #21 | 2018-12-27 ✅ Patent 10,550,188 granted on 2020-02-04
US20180371102A1
Chemistry; metallurgy

Nucleic acid-polypeptide compositions and uses thereof

 #22 | 2018-12-27 ✅ Patent 10,994,020 granted on 2021-05-04
US20180369400A1
Human necessities

Nucleic acid-polypeptide compositions and methods of inducing exon skipping

 #23 | 2017-12-21 ✅ Patent 10,876,121 granted on 2020-12-29
US20170362597A1
Chemistry; metallurgy

EGFR nucleic acids and uses thereof

 #24 | 2017-11-02 ✅ Patent 10,844,385 granted on 2020-11-24
US20170314030A1
Chemistry; metallurgy

Beta-catenin nucleic acids and uses thereof

 #25 | 2017-10-05 ✅ Patent 10,858,656 granted on 2020-12-08
US20170283806A1
Chemistry; metallurgy

KRAS nucleic acids and uses thereof

Also check out Avidity Biosciences, Inc.'s (La Jolla, United States) applicant profile with 33 patent applications submitted.

AssigneeID:

355389 ⎘